TABLE 2.
Effector | E. coli pathotype | Target | Effector activity | Gene | References |
AaiC | EAEC | Unknown (secreted) | Unknown (Hcp homologs) | BQ8769_135 | Dudley et al., 2006 |
Rhs-CT1 | STEC | Prokaryotic | Metalloprotease | CRM83_12975 | Ma et al., 2017b |
Rhs-CT3 | ETEC | Prokaryotic | Restriction endonuclease-3 | rhsA_2 | Ma et al., 2017b |
Rhs-CT5 | EHEC | Prokaryotic | RNAase (Toxin_55) | Z5014 | Ma et al., 2017b |
KatN | EHEC | Eukaryotic | Catalase intramacrophage survival | Z1921 | Wan et al., 2017 |
Tle1 | EAEC | Prokaryotic/Eukaryotic | Type VI lipase toxin | EC042_4534 | Journet and Cascales, 2016 |
Tle4 | APEC | Prokaryotic | Type VI lipase toxin | YP_542179 | Ma et al., 2014 |
Hcp-1 | NMEC | Eukaryotic | HBMECs | G8IRM9_ECOLX | Zhou et al., 2012 |
Hcp1, Hcp3 | ExPEC | Eukaryotic | Bacterial–eukaryotic cell interactions | NZ-CP006632.1 (0225 & 4211) | Peng et al., 2016 |
Hcp2 | ExPEC | Prokaryotic | Bacterial competition | NZ-CP006632.1 (0245) | Peng et al., 2016 |
Hcp-ET1 | STEC | Prokaryotic | HNH-DNase | AAF13_24945 | Ma et al., 2017a |
Hcp-ET2 | ETEC | Prokaryotic | Tle1 phospholipase | A31K_02346 | Ma et al., 2017a |
Hcp-ET3-4 | UPEC | Prokaryotic | Pyocin S3 and colicin DNase | UTI89_C0121 | Ma et al., 2017a |
XmtU | APEC | Prokaryotic | peptidase_C39 toxin | AHW84522 | Ma et al., 2017b |
VT1 | ETEC | Prokaryotic | Amidase | KX118292 | Ma et al., 2017a |
VT5 | ETEC | Prokaryotic | Lysozyme-like | KX118293 | Ma et al., 2017a |
VgrG1, VgrG2 | ExPEC | Prokaryotic/eukaryotic | Antibacterial and virulence phenotypes | PCN033_0247 PCN033_1587 | Zong et al., 2019 |